BusinessPreclinical Data Presented at American Association for Cancer Research (AACR) Annual Meeting Demonstrate Enhanced Therapeutic Benefit of Combining a PS-Targeting Antibody With Anti-PD-1 Therapy in Models of Triple Negative Breast Cancer (TNBC)By Nasdaq OMXApr 20, 2016, 12:05 PM UTC
BusinessGeron Announces Two Imetelstat Poster Presentations at the American Association for Cancer Research Annual MeetingBy Nasdaq OMXApr 20, 2016, 11:30 AM UTC
BusinessOncoMed Presents GITRL-Fc Research at the AACR Annual Meeting 2016By Nasdaq OMXApr 19, 2016, 1:00 PM UTC
BusinessMerus to Present Interim Clinical Data from Ongoing Phase 1/2 Clinical Trial of its Lead Bispecific Antibody Candidate, MCLA-128, at the American Association for Cancer Research 2016 Annual MeetingBy Nasdaq OMXApr 15, 2016, 9:06 PM UTC
BusinessOncoMed to Present Data at the American Association of Cancer Research Annual Meeting 2016By Nasdaq OMXMar 16, 2016, 8:30 PM UTC
